Bozkurt Bulakçı, B. Et Al. 2022. OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.1, no.1 , 1-7.

Bozkurt Bulakçı, B., Aday, A., Gürtekin , B., Yavuz, A. S., Öztürk, Ş., Çefle, K., ... Palanduz, A.(2022). OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.1, no.1, 1-7.

Bozkurt Bulakçı, Betül Et Al. "OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment," INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.1, no.1, 1-7, 2022

Bozkurt Bulakçı, Betül B. Et Al. "OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment." INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.1, no.1, pp.1-7, 2022

Bozkurt Bulakçı, B. Et Al. (2022) . "OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment." INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.1, no.1, pp.1-7.

@article{article, author={Betül Bozkurt Bulakçı Et Al. }, title={OCT-1 Expression in Patients with Chronic Myeloid Leukemia: A Comparative Analysis with Respect to Response to Imatinib Treatment}, journal={INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION}, year=2022, pages={1-7} }